| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.047 | 0.3 |